Literature DB >> 9951826

Diagnostic criteria of Buerger's disease.

S Shionoya1.   

Abstract

After many changes, Buerger's disease stands as an independent clinicopathologic entity, but a better understanding of Buerger's disease has been impeded by the lack of unanimous diagnostic criteria of the disease. Since specificity of Buerger's disease is characterized by peripheral ischemia of an inflammatory nature and with a self-limiting course, diagnostic criteria of Buerger's disease should be discussed from clinical point of view. Our clinical criteria for the diagnosis of Buerger's disease are: (1) smoking history; (2) onset before the age of 50 years; (3) infrapopliteal arterial occlusions; (4) either upper limb involvement or phlebitis migrans; and (5) absence of atherosclerotic risk factors other than smoking. Confident clinical diagnosis of Buerger's disease may be made only when all five requirements have been fulfilled. A set of strict and well-defined clinical diagnostic criteria is essential for any study of Buerger's disease to ensure the homogeneity of the selected patient population for valid comparisons.

Entities:  

Mesh:

Year:  1998        PMID: 9951826     DOI: 10.1016/s0167-5273(98)00175-2

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  54 in total

1.  Early outgrowth EPCs generation is reduced in patients with Buerger's disease.

Authors:  Yoshio Katsuki; Ken-ichiro Sasaki; Yasuyuki Toyama; Masanori Ohtsuka; Hiroshi Koiwaya; Takaharu Nakayoshi; Tsutomu Imaizumi
Journal:  Clin Res Cardiol       Date:  2010-07-04       Impact factor: 5.460

2.  Cerebral angiographic findings in thromboangiitis obliterans.

Authors:  Young J No; Eun M Lee; Deok H Lee; Jong S Kim
Journal:  Neuroradiology       Date:  2005-08-24       Impact factor: 2.804

3.  Stem cell therapy in patients with thromboangiitis obliterans: assessment of the long-term clinical outcome and analysis of the prognostic factors.

Authors:  Kyung-Bok Lee; Eun-Suk Kang; Ae-Kyeong Kim; Min-Hee Kim; Young-Soo Do; Kwang-Bo Park; Hong-Suk Park; Soong Ho Um; Seung-Woo Cho; Dong-Ik Kim
Journal:  Int J Stem Cells       Date:  2011-11       Impact factor: 2.500

4.  Corkscrew collaterals in Buerger's disease.

Authors:  Tsuyoshi Yoshimuta; Koichi Akutsu; Toshiya Okajima; Yuiichi Tamori; Yoshinori Kubota; Satoshi Takeshita
Journal:  Can J Cardiol       Date:  2009-06       Impact factor: 5.223

5.  Treatment of Buerger disease (thromboangiitis obliterans) with bosentan: a case report.

Authors:  Joaquin De Haro; Aurora Florez; Jose Luis Fernandez; Francisco Acin
Journal:  BMJ Case Rep       Date:  2009-05-12

6.  Thromboangitis Obliterans involving Bilateral Upper limb Extremities - A Rare Case Report from Malaysia.

Authors:  Uthamalingam Murali; Mohammad Azhar Anis Ahmad; Fatin Najihah
Journal:  J Clin Diagn Res       Date:  2017-03-01

7.  Etiopathogenesis, clinical diagnosis and treatment of thromboangiitis obliterans - current practices.

Authors:  Edwaldo Edner Joviliano; Renata Dellalibera-Joviliano; Marcelo Dalio; Paulo Rb Evora; Carlos E Piccinato
Journal:  Int J Angiol       Date:  2009

8.  Thromoboagiitis Obliterans (TAO).

Authors:  Ui-Jun Park; Dong-Ik Kim
Journal:  Int J Stem Cells       Date:  2010-05       Impact factor: 2.500

9.  Improvement in Blood Supply After "Heparin-Dextran" Therapy in Patients of Buerger's Disease with Critical Limb Ischemia.

Authors:  Sanand Bag; Arunanshu Behera; Niranjan Khandelwal; J R Bapuraj; Rakesh Kumar Vasishta
Journal:  Indian J Surg       Date:  2012-06-19       Impact factor: 0.656

10.  A phase I study of human cord blood-derived mesenchymal stem cell therapy in patients with peripheral arterial occlusive disease.

Authors:  Shin-Seok Yang; Na-Ri Kim; Kwang-Bo Park; Young-Soo Do; Kyounghwan Roh; Kyung-Sun Kang; Dong-Ik Kim
Journal:  Int J Stem Cells       Date:  2013-05       Impact factor: 2.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.